Mumbai: Mahindra & Mahindra Ltd (M&M) on Friday said that it’s board of directors, in a special meeting to review investment in SsangYong Motor Company (SYMC), has authorized the management to consider a one-time infusion of up to 40 billion KRW or USD 32 million over the next 3 months to ensure continuity of operations amid covid-19 crisis.
But given the nationwide lockdown in India and projected cash flows, M&M’s board has declined to inject any fresh equity into SYMC urging them to find alternate sources of funding.
The management and labour union of SYMC had earlier requested M&M for fresh funding as additional injection of equity to help the Korean carmaker fund its operations and pay maturing loans.